Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases

被引：15
作者：
Ostrov, Barbara E. [1 ]
机构：
[1] Penn State Hershey Childrens Hosp, Dept Pediat Pediat Rheumatol & Rheumatol, Hershey, PA 17033 USA
来源：
IMMUNOLOGICAL INVESTIGATIONS | 2015年 / 44卷 / 08期
关键词：
Autoimmune diseases; autoinflammatory diseases; biologic therapy; immunotherapy; JUVENILE IDIOPATHIC ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; PERIODIC SYNDROME; CROHNS-DISEASE; MONOCLONAL-ANTIBODIES; OPEN-LABEL; THERAPY; INFLIXIMAB; INTERLEUKIN-2;
D O I：
10.3109/08820139.2015.1093912
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
In recent decades, innovative strategies to treat patients with inflammatory, immunologically based diseases have advanced in concert with our increased understanding of molecular immunology. Recognition of the spectrum and pathophysiology of autoimmune and autoinflammatory disorders has allowed for the development of cutting-edge therapies for such patients. In this review, key immunotherapeutic approaches for treating inflammatory autoimmune disorders, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), as well as genetic autoinflammatory diseases, such as cryopyrin associated periodic syndromes, are addressed. Indications, risks and additional considerations in the use of these agents are reviewed.
引用
收藏
页码：777 / 802
页数：26
相关论文
共 50 条
[21]   Survivin modulatory role in autoimmune and autoinflammatory diseases [J].
Pahlavan, Yasamin ;
Kahroba, Houman ;
Samadi, Nasser ;
Karimi, Abbas ;
Ansarin, Khalil ;
Khabbazi, Alireza .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) :19440-19450
[22]   Are autoimmune diseases autoinflammatory: Is it time to change the paradigm? [J].
Albert, Daniel .
LUPUS, 2021, 30 (11) :1722-1724
[23]   Histone deacetylases as targets in autoimmune and autoinflammatory diseases [J].
Hamminger, Patricia ;
Rica, Ramona ;
Ellmeier, Wilfried .
ADVANCES IN IMMUNOLOGY, VOL 147, 2020, 147 :1-59
[24]   ENVIRONMENTAL AGENTS AND AUTOIMMUNE DISEASES [J].
Miller, Frederick W. .
EPIGENETIC CONTRIBUTIONS IN AUTOIMMUNE DISEASE, 2011, 711 :61-81
[25]   Interleukin-2 as immunotherapeutic in the autoimmune diseases [J].
Valencia, Alexy Orozco ;
Knirsch, Marcos Camargo ;
Ferro, Emer Suavinho ;
Stephano, Marco Antonio .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 81
[26]   Biologic agents in experimental autoimmune uveitis [J].
Paolo Giuliari, Gian ;
Sadaka, Ama ;
Hinkle, David M. .
INTERNATIONAL OPHTHALMOLOGY, 2014, 34 (01) :145-156
[27]   Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases [J].
Papamichael, Konstantinos ;
Vogelzang, Erik ;
Lambert, Jo ;
Wolbink, Gertjan ;
Cheifetz, Adam S. .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (08) :837-848
[28]   The pathogenesis of neonatal autoimmune and autoinflammatory diseases: A comprehensive review [J].
Chang, Christopher .
JOURNAL OF AUTOIMMUNITY, 2013, 41 :100-110
[29]   Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases [J].
Wigerblad, Gustaf ;
Kaplan, Mariana J. .
NATURE REVIEWS IMMUNOLOGY, 2023, 23 (05) :274-288
[30]   The Emerging Role of Interleukin-1β in Autoinflammatory Diseases [J].
Lane, Thirusha ;
Lachmann, Helen J. .
CURRENT ALLERGY AND ASTHMA REPORTS, 2011, 11 (05) :361-368
12345